中国P站

Quantitative proteomics; Biomarker discovery; Cancer research; Metabolomics; Phosphoproteomics; Antimicrobial resistance; SARS-CoV-2 replication; Extracellular vesicles; MicroRNAs; Disease diagnosis

Introduction

This article thoroughly reviews quantitative proteomics techniques, specifically for identifying biomarkers in ovarian cancer. These methods enable precise measurement of protein expression changes, which are crucial for early diagnosis, prognosis, and therapeutic target identification, thereby advancing clinical applications in oncology [1].

This review discusses the vital role of quantitative carbohydrate analysis in identifying disease biomarkers. Advanced analytical techniques for precise quantification of glycans shed light on pathological processes, playing a vital role in identifying disease biomarkers and aiding the development of diagnostic tools and therapeutic strategies [2].

This article explores the principles and methodologies of quantitative phosphoproteomics, a crucial tool for understanding cellular signaling pathways. This crucial tool provides insights into disease mechanisms, identifies therapeutic targets, and tracks drug efficacy through the precise quantitation of protein phosphorylation events, especially in cancer research [3].

This paper reviews the significant progress in applying quantitative proteomics to study antimicrobial resistance. Such techniques allow for the precise measurement of protein expression in pathogens under antibiotic stress, offering critical insights into resistance mechanisms and significantly aiding in the development of new antibacterial strategies [4].

This review highlights the power of quantitative metabolomics in identifying novel cancer biomarkers. By profiling and precisely measuring metabolic changes in biological samples, this approach reveals diagnostic, prognostic, and predictive indicators for various cancers, thus offering new avenues for early detection and personalized treatment [5].

This research utilized quantitative proteomics to uncover new host proteins critically involved in SARS-CoV-2 replication. Precisely measuring changes in protein levels during infection helps identify potential host factors that could serve as targets for antiviral therapies, contributing significantly to our understanding of COVID-19 pathogenesis [6].

This article discusses the quantitative analysis of extracellular vesicles (EVs) and their potential as biomarkers for cancer diagnosis and prognosis. It highlights various methods for precise Extracellular Vesicle (EV) quantification, emphasizing how their molecular cargo reflects disease status and can offer non-invasive tools for monitoring cancer progression and treatment response [7].

This review focuses on the application of quantitative proteomics in understanding plant responses to environmental stresses. This work details how precisely measuring protein abundance changes under various stressors provides critical insights into molecular mechanisms of adaptation and resilience, guiding strategies for improving crop tolerance and agricultural sustainability [8].

This article investigates the quantitative analysis of microRNAs (miRNAs) as a promising approach for early cancer detection. It highlights various sensitive and specific techniques for precisely measuring MicroRNA (miRNA) levels, demonstrating their potential as non-invasive biomarkers for diagnosing cancer at its earliest stages and improving patient outcomes [9].

This review covers the latest advancements in quantitative approaches for targeted proteomics, emphasizing their enhanced specificity and sensitivity. It details techniques like selected reaction monitoring and parallel reaction monitoring, showcasing their utility in precisely quantifying specific proteins or peptides, which is critical for validating biomarkers and understanding biological pathways [10].

Description

Quantitative analytical approaches have revolutionized biomarker discovery and disease understanding across a broad spectrum of research areas. These methods offer an unparalleled ability to precisely measure molecular changes within biological systems. For example, quantitative proteomics techniques are specifically applied to identify biomarkers in ovarian cancer, enabling accurate measurement of protein expression for early diagnosis, prognosis, and therapeutic target identification [1]. Similarly, quantitative metabolomics powerfully identifies novel cancer biomarkers by profiling and precisely measuring metabolic changes in biological samples, revealing crucial diagnostic, prognostic, and predictive indicators for various cancers [5]. This work opens new avenues for early detection and personalized treatment strategies.

Beyond general proteomics and metabolomics, more specialized quantitative ‘omics’ fields contribute significantly. Quantitative phosphoproteomics, for instance, is a critical tool for understanding cellular signaling pathways. It finds extensive applications in cancer research, providing deep insights into disease mechanisms, identifying therapeutic targets, and meticulously tracking drug efficacy through the precise quantitation of protein phosphorylation events [3]. In the context of infectious diseases, quantitative proteomics was instrumental in uncovering novel host proteins involved in SARS-CoV-2 replication, identifying potential host factors for antiviral therapies and thereby advancing our understanding of COVID-19 pathogenesis [6].

The scope of quantitative analysis extends to emerging non-protein and non-metabolite biomarkers. Quantitative carbohydrate analysis plays a vital role in identifying disease biomarkers, leveraging advanced analytical techniques for the precise quantification of glycans. This approach sheds light on pathological processes and aids in developing diagnostic tools and therapeutic strategies [2]. Additionally, the quantitative analysis of extracellular vesicles (EVs) shows significant potential as biomarkers for cancer diagnosis and prognosis. Various methods for precise EV quantification highlight how their molecular cargo reflects disease status, offering non-invasive tools for monitoring cancer progression and treatment response [7]. Equally important is the quantitative analysis of microRNAs (miRNAs), which represents a promising approach for early cancer detection through sensitive and specific techniques that precisely measure miRNA levels, acting as non-invasive biomarkers to improve patient outcomes [9].

The utility of quantitative proteomics also extends beyond human health. For example, it is invaluable in understanding plant responses to environmental stresses. This application details how precisely measuring protein abundance changes under various stressors provides critical insights into molecular mechanisms of adaptation and resilience, guiding strategies for improving crop tolerance and agricultural sustainability [8]. Methodological advancements continue to refine these techniques. Recent progress in applying quantitative proteomics to study antimicrobial resistance elucidates how these techniques enable precise measurement of protein expression in pathogens under antibiotic stress, offering critical insights into resistance mechanisms and aiding in developing new antibacterial strategies [4]. Furthermore, advances in quantitative approaches for targeted proteomics, such as selected reaction monitoring and parallel reaction monitoring, have greatly enhanced specificity and sensitivity, proving critical for validating biomarkers and understanding complex biological pathways [10].

In summary, the diverse array of quantitative analytical techniques discussed—from various proteomics sub-disciplines to metabolomics, carbohydrate analysis, and the study of nucleic acids and vesicles—underscores a collective effort to push the boundaries of biological understanding. These sophisticated tools are fundamental for advancing personalized medicine, improving diagnostic capabilities, and developing more effective therapeutic interventions across a wide range of diseases and biological systems.

Conclusion

Quantitative analytical techniques, spanning proteomics, phosphoproteomics, metabolomics, and carbohydrate analysis, are vital for biomarker discovery across a spectrum of biological and medical fields. These methods provide precise measurements of molecular expression and changes, which are essential for early diagnosis, prognosis, and identifying therapeutic targets in diseases like ovarian cancer [1]. For instance, quantitative carbohydrate analysis illuminates pathological processes through glycan quantification, aiding diagnostic and therapeutic development [2]. Phosphoproteomics, a crucial tool, delves into cellular signaling pathways, with extensive applications in cancer research for target identification and tracking drug efficacy via protein phosphorylation analysis [3]. Quantitative proteomics itself has seen significant progress in areas like antimicrobial resistance, where it helps elucidate resistance mechanisms in pathogens under antibiotic stress [4]. It also plays a key role in cancer biomarker discovery and understanding plant responses to environmental stresses, contributing to crop resilience [5, 8]. The technique has further been applied to infectious diseases, revealing novel host proteins involved in SARS-CoV-2 replication, thus identifying potential antiviral targets [6]. Furthermore, quantitative analysis extends to extracellular vesicles and microRNAs, offering non-invasive biomarkers for cancer diagnosis and prognosis by reflecting disease status at the molecular level [7, 9]. Advances in targeted proteomics, such as selected reaction monitoring, continue to enhance the specificity and sensitivity needed for validating biomarkers and deciphering complex biological pathways [10]. These diverse quantitative strategies collectively empower researchers to gain deeper insights into disease mechanisms, facilitating the development of innovative diagnostic and therapeutic strategies for improved patient outcomes and agricultural sustainability.

References

1. Yan L, Xiaozhi H, Wenwen H (2023) .J Cancer 14:618-632.

   , ,

2. Yangyang B, Yanli Z, Zhuhong M (2023) .Trends Analyt Chem 165:117144.

   , ,

3. Jinjin F, Li Z, Guomin Z (2023) .Biomed Pharmacother 164:114972.

   , ,

4. Jingjing W, Yanhong H, Qiaojuan J (2022) .J Proteomics 269:104724.

   , ,

5. Fangfang B, Shasha L, Jiali L (2022) .J Cell Mol Med 26:4273-4284.

   , ,

6. Yujie S, Xiaochuan Y, Min Z (2022) .J Cell Mol Med 26:792-805.

   , ,

7. Hongbo Y, Min Z, Yan Z (2021) .Mol Cell Biochem 476:1495-1510.

   , ,

8. Xin L, Qingshan C, Bin Y (2021) .Int J Mol Sci 22:4179.

   , ,

9. Jianjun D, Qi S, Min Z (2020) .Biosens Bioelectron 148:111812.

   , ,

10. Shijin W, Xiaoyue H, Mingming S (2019) .J Chromatogr A 1608:460450.

    , ,